KLIFO appoints Rene Pedersen as acting CEO

Glostrup – KLIFO, the leading Nordic drug development consultancy and clinical trial supply organization, announced today that Rene Pedersen will take on the role of acting CEO in KLIFO. This transition includes Rasmus Nelund stepping down as CEO.

René is a veteran with an extensive experience in Pharma and Biotech, including more than 20 years in various management positions at Novo Nordisk, NNE and TFS. René has served as KLIFOs CFO over the past two years, where he has played an active role in the broader management of KLIFO.

– “As KLIFO takes the next steps on its growth journey, we have concluded that a new leadership profile is needed. On behalf of the Board, I’d like to congratulate René on his appointment and express our gratitude to Rasmus for his leadership over the last two years, where he has contributed significantly to our strategic alignment of the organization and capacity expansion in clinical trial supply.” Niels Peder Nielsen, Board Chair

– “I’m honored to step into the role as Acting CEO at KLIFO and continue working alongside our strong team. KLIFO is at an exciting stage, with strong business momentum, key strategic investments, and a clear vision for the future. I look forward to leading KLIFO in its next phase of growth – strengthening our partnerships, expanding our capabilities, and delivering even greater value to our clients and stakeholders.” René Pedersen, Acting CEO